ImmunoGen, Inc. (IMGN)
(Delayed Data from NSDQ)
$2.88 USD
+0.38 (15.20%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.93 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[IMGN]
Reports for Purchase
Showing records 1 - 20 ( 282 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
ImmunoGen Agrees to AbbVie Acquisition; Downgrade to Neutral With $31.26 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Optimized Entry and Exit Levels for IMGN 112123
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Drugs
Industry: Medical - Drugs
Strong Adoption and Positive PICCOLO Update Bolster Our Confidence in Elahere; PT Up To $28; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Drugs
MIRASOL Subset Analysis Shows Elahere?s Benefit in PARPi-treated Ovarian Cancer Patients; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Industry: Medical - Drugs
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department